CUSTOMER SUPPORT CUSTOMER SUPPORT +91-9999-696-045

fund search

Individually analyse each scheme and narrow your options further Every minute detail you need to know about scheme of your choice from asset holdings, best and worst performance and fund returns to competitor analysis; is available in the Fund card.
Using this report card, you can gather vital information regarding the future health of the scheme by analysing the top 10 companies and sectors it invests in. You can also track the fund management’s track record and analyse the philosophy behind scheme’s holdings. All the parameters in the fund card are extremely important and can go a long way in helping you decide which scheme to invest your money.

NAV As on Mar-05-2021

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

Top 10 Holdings
Company
(%)
Sun Pharmaceutical Industries Ltd.
10.28
Dr. Reddys Laboratories Ltd.
10.25
Cipla Ltd.
9.61
Lupin Ltd.
9.02
Divis Laboratories Ltd.
8.27
Aurobindo Pharma Ltd.
7.11
Apollo Hospitals Enterprise Ltd.
5.15
Torrent Pharmaceuticals Ltd.
3.27
Alkem Laboratories Ltd.
3.15
Zydus Wellness Ltd.
3.07
Top 10 Sectors
Sectors
(%)
Pharmaceuticals & Drugs
81.78
Hospital & Healthcare Services
11.20
Consumer Food
3.07
Chemicals
2.63
Asset Allocation
Market Cap Allocation
  Scheme Benchmark ()
Large-Cap 69.13 NA
Mid-Cap 24.65 NA
Small-Cap 4.90 NA

Best and Worst Performance and Ratios

Best Performance in a year
Period Fund (%) Benchmark (%)
Year 07/10/19
to 08/10/20
60.7072.45
Worst Performance in a year
Period Fund (%) Benchmark (%)
Year 12/07/19
to 13/07/20
25.3030.35
Ratios
Standard Deviation[%] 29.28
Sharpe Ratio [%] 0.46
Turnover Ratio [%] 0.52
Modified Duration
YTM
Riskometer
very high risk

Investors understand that their principal will be at very high risk

Fund Details
Category
Sector Funds
Inception Date (Regular Plan)
10-Jul-19
Inception Date (Direct Plan)
10-Jul-19
Expense Ratio (Direct Plan) %
0.99
Expense Ratio (Regular Plan) %
2.74
Investing Style
Large Growth
Fund Manager
Dhaval Shah
Scheme Benchmark
S&P BSE HEALTH CARE - TRI
AUM (Rs. in Cr.)
441.97
Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Growth Chart of the Scheme Versus Benchmark (SIP value Rs10,000)
Aditya Birla SL Pharma & Healthcare Fund-Reg(G) S&P BSE Health Care - TRI

Performance Comparison with similar Schemes and Benchmark